1.Effect of ursolic acid on osteogenic differentiation of human periodontal ligament stem cells
Qian ZHENG ; Pingping LIU ; Yujie GU ; Lei XIE
Chinese Journal of Tissue Engineering Research 2025;29(1):80-86
BACKGROUND:Ursolic acid can promote the directed differentiation of bone marrow mesenchymal stem cells into osteoblasts.However,there are few reports on whether ursolic acid has osteogenic effect on human periodontal ligament stem cells. OBJECTIVE:To investigate the effect of ursolic acid on proliferation and osteogenic differentiation of human periodontal ligament stem cells. METHODS:The human periodontal ligament stem cells were isolated and cultured.Passage 3 cells were selected and treated with ordinary medium containing different concentrations(0,1,2,4,6,8 μmol/L)of ursolic acid.After intervention for 1,3,5,7 days,the cell proliferation was detected by CCK-8 assay and the appropriate intervention concentration was screened.Passage 3 human periodontal ligament stem cells were treated with osteogenic induction solution containing 0,1,2,4 μmol/L ursolic acid,respectively.After 7 days of intervention,the mRNA expressions of alkaline phosphatase,Runx2,and osteocalcin were detected by qRT-PCR.After 14 days of intervention,the formation of mineralized nodules was observed by alizarin red staining.Passage 3 human periodontal ligament stem cells were taken and the control group was added with osteogenic induction solution;the ursolic acid group and the antagonist group were added with osteogenic induction solution containing ursolic acid(2 μmol/L)and the bone morphogenetic protein signaling pathway antagonist Noggin,respectively.The ursolic acid+antagonist group was added with osteogenic induction solution containing ursolic acid(2 μmol/L)and Noggin,the inhibitor of bone morphogenetic protein signaling pathway,and cultured for 7 days.qRT-PCR and western blot assay were used to detect the mRNA and protein expressions of bone morphogenetic protein 2,Smad1,osteopontin,and Runx2. RESULTS AND CONCLUSION:(1)1,2,4 μmol/L ursolic acid could promote the proliferation of human periodontal ligament stem cells.6,8 μmol/L ursolic acid could inhibit the proliferation of human periodontal ligament stem cells,and 1,2,4 μmol/L ursolic acid was selected to intervene in subsequent experiments.(2)Compared with 0 μmol/L,1,2,4 μmol/L ursolic acid could promote the expression of alkaline phosphatase,Runx2,and osteocalcin mRNA and the formation of mineralized nodules(P<0.05),and the effect of 2 μmol/L ursolic acid was the most significant.(3)Compared with the control group,the mRNA and protein expressions of bone morphogenetic protein 2,Smad1,osteopontin,and Runx2 in the ursolic acid group were increased(P<0.05),while mRNA and protein expressions of the above indexes were decreased in the antagonist group(P<0.05).Compared with the ursolic acid group,mRNA and protein expressions of above indexes were decreased in ursolic acid+antagonist group(P<0.05).(4)The results indicate that ursolic acid promotes osteogenic differentiation of human periodontal ligament stem cells through bone morphogenetic protein signaling pathway.
2.Effect of neuroglial calcium signaling on neurological impairment in ischemic stroke
Yujie CHEN ; Lei WANG ; Chen ZHENG
Chinese Journal of Pathophysiology 2024;40(3):551-556
Stroke is one of the leading causes of disability and death in China,but its mechanism has not been thoroughly elucidated.As an important class of cells in maintaining neurological homeostasis,the intracellular calcium signaling of glial cells plays a dual role in mitigating and exacerbating neuronal damage in stroke and largely determines the progression and outcome of stroke.In this review of the literature,focusing on astrocytes,which account for the largest proportion of glial cells,we review the mechanism of glial calcium signaling after stroke and its effect on post-stroke neuro-logical function,to provide reference for post-stroke neuroprotection and repair.
3.Survey on COVID-19 among residents in Anhui province in the new stage of epidemic prevention and control
Qian ZHU ; Sai HOU ; Meng ZHU ; Yujie FENG ; Biao ZHU ; Lei GONG ; Jiabing WU
Acta Universitatis Medicinalis Anhui 2024;59(8):1455-1459
Objective To understand current epidemic trend of coronavirus disease-2019(COVID-19)in Anhui province in the optimization policy stage,and to analyze the pathogenic characteristics of severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)in different population.Methods Using a cross-sectional survey design,from December 19 to 20,2022,an online questionnaire survey was conducted among residents of Anhui province through the official Wechat public accounts of provincial and municipal institutions with high traffic,to collect infor-mation on the incidence and clinic situation of COVID-19.The chi-square test was used to compare the proportion of COVID-19 suspected symptoms in different regions,ages and occupations.Results A total of 69 014 question-naires were distributed and 68 232 valid questionnaires were recovered with an effective rate of 98.97%.The pro-portion of the participants with COVID-19 suspected symptoms in the past 2 weeks was 51.37%,of which 77.88%self-medicated at home.The top three cities were Bozhou,Fuyang and Bengbu.The age group of 15-59 had the highest proportion of COVID-19 suspected symptoms(51.96%).Among various occupations,service providers had the highest proportion of COVID-19 suspected symptoms(61.07%).70.20%of the respondents felt anxious about the infection of SARS-CoV-2 and thought it was more serious than the flu.Conclusion The relatively high number of the infected cases and the anxiety of the people are all challenges faced by Anhui province in the stage of optimizing policies.Under the new situation of the epidemic,it is necessary to continuously monitor the local preva-lent strains and strengthen the monitoring of clinical symptoms of the infected cases,and effectively control the speed of the virus spread through public health policies and various economic and publicity measures,so as not to cause a run on medical resources and excessive excess deaths.
4.Research on the association between the DYS570 microvariant and Y-SNP haplogroup in Kunming
Lei HUANG ; Guangsen YANG ; Yujie FAN ; Xueyun CHEN ; Zhu YANG ; Wei WANG ; Wei HE ; Dian ZHAI ; Jun DENG ; Yiyan ZHANG ; Baowen CHENG
Chinese Journal of Forensic Medicine 2024;39(1):82-87
Objective To investigate the association between microvariants at locus DYS570 and Y-SNPs haplogroup.Methods 89 Y-SNPs and 34 Y-STRs in AIYSNP42,AIYSNP47 and YfilerTM Platinum kits were used to detect the genotype of 116 microvariants at locus DYS570 in Kunming,and the Set-B kit was used to detect the core repeat sequences of the DYS570 locus.The data were statistically analyzed by direct counting method.Then,a network map was drawn by Network 10.2,in order to visualize the genetic information of the sample.Results The results demonstrated that 111 DYS570/18.3-21.3 samples had a core repeat sequence of TTT[TITC]18-21,belonging to subgroup O2a2b1a1a1a4-F14494.A DYS570/20.3 sample had a core repeat sequence of[TTTC]15TTC[TTTC]5,belonging to O2a1b1a1a1a1e-F1365 subgroup.A DYS570/17.1 sample had a core repeat sequence of[TTTC]17 T,belonging to the O2a1b1a1a1a-F11 subgroup.Three DYS570(19.2)samples had[TTTC]3 TT[TTTC]16,belonging to the D1a1a-M15 haplogroup.Conclusion The results indicated that the microvariant with the same core repeat structure at locus DYS570 was associated with haplogroups,and the ancestry origin of samples can be inferenced from microvariant characteristics during the practice of forensic medicine.
5.Efficacy of endoscopic radial incision with esophageal stent placement for the treatment of benign esophageal stenosis
Kaiyue WANG ; Yichao YANG ; Dongxuan ZHANG ; Lei HAN ; Yujie CHEN ; Ying XIONG
China Journal of Endoscopy 2024;30(10):53-61
Objective To compare the efficacy of endoscopic bougie/balloon dilation(EBD),endoscopic radial incision(ERI),and ERI combined with esophageal stent placement(ESP)for the treatment of benign esophageal stenosis,and evaluate the feasibility and safety of ERI combined with ESP for the treatment of benign esophageal stenosis.Methods 48 Patients with benign esophageal stenosis from January 2019 to January 2023 were recruited,and divided into EBD group(n=24),ERI group(n=17)and ERI+ESP group(n=7).The differences in operating success,restenosis and complications among the three groups were compared.Results The number of previous endoscopic treatment in ERI+ESP group was more than that in EBD group and ERI group,and the differences were statistically significant(P<0.05).Technical success was achieved in 23 cases and clinical remission in 23 cases in EBD group,technical success in 16 cases and clinical remission in 15 cases in ERI group,technical success in 7 cases and clinical remission in 7 cases in ERI+ESP group.There was no significant difference in technical success rate and clinical remission rate among the three groups(P>0.05).After 3 months of follow-up,there were 15,9 and 1 cases of esophageal restenosis in the EBD group,ERI group and ERI+ESP group,respectively.There was no significant difference in the rate of esophageal restenosis among the 3 groups(P>0.05).After 6 months of follow-up,there were 20 cases of esophageal restenosis in the EBD group,13 cases in the ERI group and 1 case in the ERI+ESP group.The rate of esophageal restenosis in the ERI+ESP group was significantly lower than that in the EBD group and the ERI group(P<0.05).However,there was no statistically significant difference in the esophageal restenosis rate between the EBD group and the ERI group(P>0.05).The time to the first postoperative restenosis was 74.00(48.75,159.00)days in the EBD group,84.00(54.50,195.00)days in the ERI group,and 250.00(206.00,289.00)days in the ERI+ESP group.The time to the first postoperative restenosis was longer in the ERI+ESP group than that in the EBD and ERI groups.The differences were statistically significant(P<0.05),but there was no significant difference in restenosis time between EBD group and ERI group(P>0.05).There were 5,5 and 3 cases of complications in the EBD group,ERI group and ERI+ESP group,respectively,and there was no significant difference in the incidence of complications among the three groups(P>0.05).Conclusion ERI+ESP is comparable to EBD and ERI in terms of technical success and short-term clinical remission rate for the treatment of benign esophageal stenosis,and is superior to EBD and ERI in terms of long-term restenosis rate and restenosis time,with no influence on the occurrence of complications.
6.Progress in Diagnosis and Treatment of Lung Cancer Associated with Cystic Airspaces.
Jinxu YANG ; Ying CHEN ; Yujie LEI ; Yunchao HUANG
Chinese Journal of Lung Cancer 2023;26(10):774-781
Lung cancer associated with cystic airspaces (LCCA) is a type of lung cancer characterized by the presence of cystic cavities in or around the tumor on imaging. Due to its high potential for misdiagnosis or underdiagnosis, the prognosis of LCCA patients is poor, necessitating further large-scale clinical studies to elucidate its characteristics. Currently, four imaging classification systems exist, and there has been a progressive increase in attention towards LCCA, particularly with regard to the study of its imaging features. The results indicate a correlation between the pathological features and imaging findings of LCCA; however, research on driver gene mutations and molecular subtyping associated with lung cancer remains insufficient. Due to the challenges associated with early diagnosis and the poorer prognosis compared to general types of lung cancer, this paper comprehensively reviews the research progress on LCCA, including its definition, etiology, pathogenesis, imaging features, histological and pathological features, treatment, and prognosis, aiming to serve as a valuable resource for clinical decision-making.
.
Humans
;
Lung Neoplasms/genetics*
;
Tomography, X-Ray Computed/methods*
;
Prognosis
7.Detection rate of depression symptoms and its influencing factors in breast cancer patients during chemotherapy in China: a meta-analysis and systematic review
Yujie ZHANG ; Shanyan LEI ; Fang YANG
Chinese Journal of Health Management 2023;17(8):608-613
Objective:To systematically evaluate the prevalence of depressive symptoms and its influencing factors in breast cancer patients during chemotherapy in China.Methods:The databases such as CNKI, Wanfang Data, VIP, PubMed, Web of Science and Embase were searched with retrieval terms of breast cancer, breast tumor, chemotherapy, depressive symptom, mental health, melancholia, Chinese, etc for the literature related to the prevalence of depressive symptoms in breast cancer patients during chemotherapy in China. Relevant literature from the establishment of the databases to August 2022 were retrieved. Two researchers screened the literature independently, extracted data and evaluated the risk of bias in the included studies, and prevalence of depressive symptoms and its influencing factors in breast cancer patients during chemotherapy in China were systematically evaluated by using RevMan 5.3 and Stata 14.1 software.Results:A total of 18 studies were included, including 2 678 subjects. Meta-analysis results showed that the prevalence of depressive symptom in breast cancer patients in China was 51.60% (95% CI: 44.10%-55.10%). The results of subgroup analysis showed that age ( OR=2.55, 95% CI: 1.26-5.14), educational level ( OR=2.01, 95% CI: 1.01-3.98), marital status ( OR=0.50, 95% CI: 0.29-0.86), occupational status ( OR=3.29, 95% CI: 1.04-10.46), clinical staging ( OR=0.32, 95% CI: 0.22-0.46) and frequency of chemotherapy ( OR=0.39, 95% CI: 0.17-0.86) were the influencing factors of depressive symptoms in breast cancer patients during chemotherapy in China (all P<0.05). Conclusions:The prevalence of depressive symptoms in breast cancer patients during chemotherapy in China is high. Breast cancer patients undergoing chemotherapy who are under 50 years old, having a high school education or lower, are not married, currently employed, and in clinical stage 3-4 and receiving more than 4 chemotherapy cycles are more likely to experience depressive symptoms.
8.Rapid Characterization of Chemical Constituents in Dayuanyin by UPLC-Q-Exactive Orbitrap MS
Kangning XIAO ; Ming SU ; Yujie HOU ; Xinjun ZHANG ; Yuecheng LIU ; Xinrui LI ; Dandan SUN ; Ruixue LIANG ; Lei CAO ; Shanxin LIU
Chinese Journal of Experimental Traditional Medical Formulae 2023;29(10):1-12
ObjectiveTo characterize the chemical constituents of Dayuanyin based on ultra-performance liquid chromatography-quadrupole/electrostatic field orbitrap mass spectrometry(UPLC-Q-Exactive Orbitrap MS). MethodThe detection was performed on a Thermo Acclaim™ RSLC 120 C18 column(2.1 mm×100 mm, 2.2 μm), the mobile phase was acetonitrile(A)-0.1% formic acid aqueous solution(B) for gradient elution (0-7.5 min, 10%-19%A; 7.5-12 min, 19%-22.5%A; 12-23 min, 22.5%-27%A; 23-27 min, 27%-56%A; 27-35 min, 56%-84%A; 35-36 min, 84%-90%A), the flow rate was 0.3 mL·min-1, and the column temperature was 30 ℃. The data were collected in the positive and negative ion modes by heated electrospray ionization(HESI), and the detection range was m/z 80-1 200. Combining the retention time of the reference substance, fragment ions, databases such as PubChem and related literature, Xcalibur 3.0 was used to identify the chemical constituents of Dayuanyin. ResultA total of 161 compounds were identified, including 14 alkaloids, 60 flavonoids, 16 terpenoids, 26 saponins, 18 phenylpropanoids, 16 organic acids and 11 others. ConclusionThe established method can effectively and quickly identify the chemical components in Dayuanyin, and clarify its chemical composition, which can provide a basis for the development of compound preparations of this famous classical formula.
9.Comparison of transfemoral transcatheter aortic valve replacement under local versus general anesthesia in patients with aortic stenosis: A systematic review and meta-analysis
Xiangxiang HAN ; Shidong LIU ; Jialu WANG ; Xiang LEI ; Zhenxiu WANG ; Yujie WANG ; Shuai DONG ; Bing SONG
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery 2023;30(04):597-604
Objective To systematically review the efficacy and safety of transfemoral transcatheter aortic valve replacement (TFTAVR) under local anesthesia (LA) and general anesthesia (GA). Methods Electronic databases including PubMed, EMbase, The Cochrane Library, Web of Science, CNKI, WanFang and CBM were searched to collect randomized controlled trial and cohort studies on clinical outcomes of TFTAVR under LA and GA from inception to September 2020. Two authors independently screened literature, extracted data and assessed the quality of studies, and a meta-analysis was performed by using Stata 16.0 software. Results A total of 30 studies involving 52 087 patients were included in this study. There were 18 719 patients in the LA group and 33 368 patients in the GA group. The results of meta-analysis showed that the in-hospital all-cause mortality rate [RR=0.65, 95%CI (0.45, 0.94), P=0.021], 30-day all-cause mortality rate [RR=0.73, 95%CI (0.62, 0.86), P<0.001], 30-day stroke [RR=0.82, 95%CI (0.68, 0.98), P=0.025], cardiac arrest [RR=0.50, 95%CI (0.34, 0.73), P<0.001], ICU stay time [RR=−6.86, 95%CI (−12.31, −1.42), P=0.013], and total hospital stay time [RR=−2.02, 95%CI (−2.59, −1.45), P<0.001] in the LA group were all better than those in the GA group. There was no significant difference in the in-hospital stroke [RR=0.83, 95%CI (0.69, 1.00), P=0.053], in-hospital myocardial infarction (MI) [RR=1.74, 95%CI (0.43, 7.00), P=0.434], or 30-day MI [RR=0.77, 95%CI (0.42, 1.42), P=0.404] between the two groups. Conclusion LA provides a safe and effective way to induce sedation without intubation, and may be a good alternative to GA for TFTAVR.
10.Mediating effect of work-family conflict and work-family enrichment in the relationship between job demands and subjective well-being among nurses
Yujie ZHANG ; Shanyan LEI ; Fang YANG
China Occupational Medicine 2023;50(2):170-174


Result Analysis
Print
Save
E-mail